116 related articles for article (PubMed ID: 23235124)
1. Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation.
Sjöberg B; Qureshi AR; Anderstam B; Alvestrand A; Bárány P
Blood Purif; 2012; 34(3-4):290-7. PubMed ID: 23235124
[TBL] [Abstract][Full Text] [Related]
2. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
[TBL] [Abstract][Full Text] [Related]
3. Pentraxin 3 and C-reactive protein as inflammatory markers after a kidney transplant.
Gursu M; Celik K; Ozturk S; Turkmen A; Gorcin S; Kocak B; Sari S; Koldas M; Feyizoglu H; Kazancioglu R
Exp Clin Transplant; 2014 Aug; 12(4):295-9. PubMed ID: 24568622
[TBL] [Abstract][Full Text] [Related]
4. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
[TBL] [Abstract][Full Text] [Related]
5. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
[TBL] [Abstract][Full Text] [Related]
6. Changes in circulating biomarkers during a single hemodialysis session.
Yamamoto T; Nascimento MM; Hayashi SY; Qureshi AR; Waniewski J; Brodin LÅ; Anderstam B; Lind B; Riella MC; Seeberger A; Lindholm B
Hemodial Int; 2013 Jan; 17(1):59-66. PubMed ID: 22716238
[TBL] [Abstract][Full Text] [Related]
7. A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients?
Tessitore N; Poli A; Bedogna V; Corazza L; Campostrini N; Atti M; Sereni L; Castagna A; Girelli D; Pessolano G; Lupo A
J Nephrol; 2018 Apr; 31(2):297-306. PubMed ID: 28353202
[TBL] [Abstract][Full Text] [Related]
8. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis.
den Hoedt CH; Bots ML; Grooteman MP; van der Weerd NC; Mazairac AH; Penne EL; Levesque R; ter Wee PM; Nubé MJ; Blankestijn PJ; van den Dorpel MA;
Kidney Int; 2014 Aug; 86(2):423-32. PubMed ID: 24552852
[TBL] [Abstract][Full Text] [Related]
9. Effect of a single hemodialysis session on inflammatory markers.
Bitla AR; Reddy PE; Manohar SM; Vishnubhotla SV; Pemmaraju Venkata Lakshmi Narasimha SR
Hemodial Int; 2010 Oct; 14(4):411-7. PubMed ID: 20955274
[TBL] [Abstract][Full Text] [Related]
10. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
[TBL] [Abstract][Full Text] [Related]
11. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
[TBL] [Abstract][Full Text] [Related]
12. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
16. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
[TBL] [Abstract][Full Text] [Related]
18. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]